Acute respiratory failure is a sudden inability of the lungs to perform their basic job: getting enough oxygen into the blood, removing enough carbon dioxide, or both. It develops over hours to days and is a medical emergency. Roughly half of patients admitted to an ICU with acute respiratory failure do not survive to 28 days, making rapid recognition and treatment critical.
Two Types of Respiratory Failure
Respiratory failure is classified into two types based on which side of the gas exchange equation breaks down.
Type 1 (hypoxemic): Blood oxygen drops dangerously low while carbon dioxide levels remain normal. This happens when the lung tissue itself is damaged or filled with fluid, so oxygen can’t cross from the air sacs into the bloodstream. Pneumonia, severe COVID-19, and acute respiratory distress syndrome (ARDS) are common causes.
Type 2 (hypercapnic): Carbon dioxide builds up in the blood because the body isn’t breathing deeply or frequently enough to expel it. Oxygen levels drop as well, but the core problem is ventilation, not the lung tissue itself. This can happen even in people with otherwise healthy lungs if something prevents them from breathing adequately, such as a drug overdose, severe obesity, or a neuromuscular disease like ALS.
Common Causes
The causes fall into two broad categories: problems that start in the lungs and problems that originate elsewhere in the body.
Pneumonia is the single most common trigger. Bacterial, viral, or fungal infections inflame the air sacs and fill them with fluid, blocking oxygen transfer. Aspiration of stomach contents into the lungs is another frequent pulmonary cause, as are severe asthma attacks and COPD flare-ups. Vaping-associated lung injury emerged as a newer cause in 2018, primarily affecting young, otherwise healthy users of e-cigarettes.
Outside the lungs, sepsis (a bodywide infection response) tops the list. Pancreatitis, major trauma with significant blood loss, and drug overdoses that suppress the brain’s breathing drive are also well-established triggers. Certain medications can directly injure lung tissue as well, particularly some chemotherapy drugs and newer immunotherapy agents. Alcohol use, cigarette smoking, and exposure to air pollution all raise the baseline risk of developing respiratory failure when one of these triggers hits.
Recognizable Signs and Symptoms
The body sends visible distress signals when it can’t get enough oxygen or offload carbon dioxide. Rapid breathing is typically the first sign, often accompanied by a feeling of breathlessness even at rest or while trying to speak. You may notice the muscles of the neck and between the ribs pulling inward with each breath, a sign the body is recruiting extra muscles to force air in.
Skin color changes are telling. A bluish tint around the lips, fingertips, or nail beds indicates that blood oxygen has dropped significantly. Confusion, agitation, or drowsiness reflect the brain’s sensitivity to low oxygen and high carbon dioxide. In severe cases, consciousness fades entirely. Sweating, a racing heart, and an inability to speak in full sentences round out the picture. Any combination of these symptoms developing over hours warrants emergency care.
How It’s Diagnosed
Diagnosis centers on a blood test called an arterial blood gas, which measures oxygen and carbon dioxide levels directly from an artery (usually the wrist). In Type 1 failure, blood oxygen is critically low while carbon dioxide is normal. In Type 2, carbon dioxide is elevated and oxygen is low. These measurements, combined with the clinical picture, tell the medical team which type of failure is occurring and guide the treatment approach.
Chest X-rays or CT scans help identify the underlying cause, whether it’s fluid in the lungs, a collapsed lung, or widespread infection. Other blood work checks for signs of infection, organ stress, and the body’s acid-base balance.
Treatment: Oxygen and Breathing Support
Treatment follows a stepwise approach, starting with the least invasive option and escalating as needed. The immediate priority is restoring adequate oxygen levels.
- Nasal cannula: A lightweight tube delivering oxygen through the nostrils, suitable for mild cases.
- Face masks: Venturi masks allow precise oxygen concentrations up to about 50%, while non-rebreather masks deliver higher levels for more severe drops.
- High-flow nasal cannula: Delivers warm, humidified oxygen at much higher rates, often enough to avoid a ventilator in moderate cases.
- Non-invasive ventilation (CPAP or BiPAP): A tight-fitting mask pushes pressurized air into the lungs, helping keep the air sacs open. Joint guidelines from the European Respiratory Society and American Thoracic Society support its use for several forms of acute respiratory failure, particularly COPD flare-ups and fluid overload in the lungs.
- Mechanical ventilation: When a patient can’t maintain adequate breathing on their own, a breathing tube is placed in the airway and connected to a ventilator. This is typically necessary when consciousness drops significantly, when the breathing drive is dangerously low, or when less invasive methods fail to improve oxygen or carbon dioxide levels.
Beyond breathing support, treatment targets the underlying cause. Antibiotics for pneumonia, drainage for fluid collections, reversal agents for drug overdoses, and steroids in specific situations like early severe ARDS all play a role. Corticosteroids given early in severe ARDS have shown reductions in ICU mortality (roughly 21% versus 43% with placebo in one trial), along with shorter time on the ventilator. However, starting steroids more than two weeks after the onset of ARDS has been associated with worse outcomes, so timing matters.
Recovery and Long-Term Effects
Surviving acute respiratory failure, particularly when it progresses to ARDS and requires ICU care, is only the beginning of recovery. The effects extend well beyond the lungs and can persist for years. This cluster of lasting problems is known as post-intensive care syndrome.
Cognitive impairment is strikingly common. Over three-quarters of ARDS survivors show signs of cognitive problems at hospital discharge. More than half still have measurable deficits at one year, and roughly one in five carry persistent problems at five years. Memory, executive function, and learning are the areas most affected, with half of patients scoring below the 6th percentile on cognitive testing two years out.
Psychological effects are nearly as widespread. In follow-up studies, about 36% of survivors experience clinical depression, 42% report significant anxiety, and 24% develop post-traumatic stress disorder. These rates remain elevated even eight years after hospitalization.
Physical recovery is slow. About one-third of ARDS patients leave the hospital with measurable muscle weakness, and at least half continue to experience weakness that resolves only gradually over the following years. Lung function testing typically shows a mild to moderate reduction in how efficiently the lungs transfer oxygen to the blood. These reductions tend to stabilize within the first few months after discharge and don’t worsen over time, but they may never fully return to baseline.
The combination of cognitive, psychological, and physical impairment means that many survivors face reduced quality of life and ongoing healthcare needs long after leaving the hospital. Rehabilitation programs that address all three dimensions, rather than just lung function, produce the best outcomes for people rebuilding their lives after respiratory failure.